OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN LOW GRADE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN LOW GRADE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN LOW GRADE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests gentler hormone pill against harsh chemo for rare ovarian cancer
Disease control OngoingThis study aims to find out if a daily hormone pill (letrozole) works as well as or better than standard chemotherapy (paclitaxel/carboplatin) followed by the same pill for patients with advanced low-grade ovarian, fallopian tube, or peritoneal cancer. It involves 450 women who h…
Matched conditions: OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug duo aims to stall tough cancers driven by common mutation
Disease control OngoingThis study is testing whether taking two oral drugs together—palbociclib and binimetinib—is better than taking one of them alone for controlling advanced cancers that have specific genetic changes called RAS mutations. It focuses on certain hard-to-treat cancers like low-grade ov…
Matched conditions: OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC